Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

189.76
Delayed Data
As of Aug 31
 +0.81 / +0.43%
Today’s Change
128.50
Today|||52-Week Range
314.88
+21.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues1.8M2.4M1.6M1.7M
 
 
 
 
 
Depreciation And Amortization410.6K201.3K105.7K442.8K
 
 
 
 
 
 
Operating ExpensesGross Income1.4M------
 
 
General Expenses15.2M21.2M41.0M114.5M
 
 
 
 
 
Research And Development11.4M16.2M27.9M80.3M
 
 
 
 
 
Total Operating Expenses15.6M21.4M41.1M114.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.8M-18.9M-39.5M-113.2M
 
 
 
 
 
Extraordinary Credit1.0M0.000.000.00
 
 
Extraordinary Charge0.00-24.8M-28.4M-170.8M
 
 
 
 
Interest Expense On Debt13.5K----0.00
 
 
Other Expenses0.0087.8K100.4K776.1K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.7M-43.6M-67.8M-283.2M
 
 
 
 
 
Preferred Dividend0.00-2.6M0.000.00
 
 
Net Income-12.7M-43.6M-67.8M-283.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.7M6.3M18.0M20.8M
 
 
 
 
 
Shares To Calculate EPS Diluted15.7M6.3M18.0M20.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.73-$7.36-$3.76-$13.63
 
 
 
 
 
EPS Diluted-$0.81-$7.36-$3.76-$13.63